Leslee J. Shaw, PhD

Antonio Bellasi, MD
Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA; and Ospedale S. Paolo, Università degli Studi di Milano, Milano, Italy

Paolo Raggi, MD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

C. Noel Bairey Merz, MD
Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Professor of Medicine, University of California, Los Angeles

Leslee J. Shaw, PhD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

Address: Leslee J. Shaw, PhD, Professor of Medicine, Emory University School of Medicine, 1256 Briarcliff Road NE, Atlanta, GA 30306; e-mail: leslee.shaw@emory.edu

Dr. Bairey Merz has indicated serving as a consultant for the American College of Cardiology Foundation, AusAm, Bayer, CardioVasc Clin Trials, Dunn Group, Kieris Solutions, Ideon-Fujisawa, Pfizer, Merck, KOS, LABiomed, National Institutes of Health (NIH Study Section), CV Therapeutics, Rodale Press, Sanofi-Aventis, University of Pittsburgh, and VHA; lecturing for the American Heart Association, Charlotte Carolinas Healthcare System, Mayo Clinic, Institute for Medical Education of the American College of Cardiology, Rush University, Merck, National Youth Leadership Forum, Gacheon Medical School (Korea), Spanish Cardiac Society, Nuclear Cardiology, and Wake Forest University; and owning stock in Boston Scientific, Eli Lilly, Johnson and Johnson, and Medtronic corporations.

Antonio Bellasi, MD
Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA; and Ospedale S. Paolo, Università degli Studi di Milano, Milano, Italy

Paolo Raggi, MD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

C. Noel Bairey Merz, MD
Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Professor of Medicine, University of California, Los Angeles

Leslee J. Shaw, PhD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

Address: Leslee J. Shaw, PhD, Professor of Medicine, Emory University School of Medicine, 1256 Briarcliff Road NE, Atlanta, GA 30306; e-mail: leslee.shaw@emory.edu

Dr. Bairey Merz has indicated serving as a consultant for the American College of Cardiology Foundation, AusAm, Bayer, CardioVasc Clin Trials, Dunn Group, Kieris Solutions, Ideon-Fujisawa, Pfizer, Merck, KOS, LABiomed, National Institutes of Health (NIH Study Section), CV Therapeutics, Rodale Press, Sanofi-Aventis, University of Pittsburgh, and VHA; lecturing for the American Heart Association, Charlotte Carolinas Healthcare System, Mayo Clinic, Institute for Medical Education of the American College of Cardiology, Rush University, Merck, National Youth Leadership Forum, Gacheon Medical School (Korea), Spanish Cardiac Society, Nuclear Cardiology, and Wake Forest University; and owning stock in Boston Scientific, Eli Lilly, Johnson and Johnson, and Medtronic corporations.

Antonio Bellasi, MD
Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA; and Ospedale S. Paolo, Università degli Studi di Milano, Milano, Italy

Paolo Raggi, MD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

C. Noel Bairey Merz, MD
Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Professor of Medicine, University of California, Los Angeles

Leslee J. Shaw, PhD
Professor of Medicine, Division of Cardiology, Department of Medicine, Emory University, Atlanta, GA

Address: Leslee J. Shaw, PhD, Professor of Medicine, Emory University School of Medicine, 1256 Briarcliff Road NE, Atlanta, GA 30306; e-mail: leslee.shaw@emory.edu

Dr. Bairey Merz has indicated serving as a consultant for the American College of Cardiology Foundation, AusAm, Bayer, CardioVasc Clin Trials, Dunn Group, Kieris Solutions, Ideon-Fujisawa, Pfizer, Merck, KOS, LABiomed, National Institutes of Health (NIH Study Section), CV Therapeutics, Rodale Press, Sanofi-Aventis, University of Pittsburgh, and VHA; lecturing for the American Heart Association, Charlotte Carolinas Healthcare System, Mayo Clinic, Institute for Medical Education of the American College of Cardiology, Rush University, Merck, National Youth Leadership Forum, Gacheon Medical School (Korea), Spanish Cardiac Society, Nuclear Cardiology, and Wake Forest University; and owning stock in Boston Scientific, Eli Lilly, Johnson and Johnson, and Medtronic corporations.